Maria Buti

Also affiliated with Vall d'Hebron Hospital Universitari

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality”.

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

Journal of Clinical Investigation(2021)10.1172/jci152386

N/A

0DataRank · unranked

124 citations

Sara Pigazzini, Frauke Degenhardt, Mattia Cordioli, Guillaume Butler‐Laporte, Douglas Maya-Miles +42 more

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

medRxiv(2021)10.1101/2021.03.07.21252875

N/A

0DataRank · unranked

29 citations

Sara Pigazzini, Frauke Degenhardt, Mattia Cordioli, Guillaume Butler‐Laporte, Douglas Maya‐Miles +44 more

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

The Lancet. Gastroenterology & hepatology(2023)10.1016/s2468-1253(23)00197-8

N/A

0DataRank · unranked

412 citations

Ivane Gamkrelidze, Calvin Q. Pan, Jidong Jia, Thomas Berg, Richard T. Gray +95 more

EASL Clinical Practice Guidelines on hepatitis delta virus

Journal of Hepatology(2023)10.1016/j.jhep.2023.05.001

N/A

0DataRank · unranked

262 citations

G. Ricco, Francesco Negro, Heiner Wedemeyer, Cihan Yurdaydın, Tarik Asselah +6 more

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

Hepatology(2023)10.1097/hep.0000000000000431

N/A

0DataRank · unranked

112 citations

Maria Buti, Pietro Lampertico, Hannah M. Lee, Marc G. Ghany

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

Journal of Hepatology(2023)10.1016/j.jhep.2023.06.002

N/A

0DataRank · unranked

103 citations

Maria Buti, Pietro Lampertico, Hannah M. Lee, Marc G. Ghany

The elimination of hepatitis D as a public health problem: Needs and challenges

Journal of Viral Hepatitis(2023)10.1111/jvh.13891

N/A

0DataRank · unranked

17 citations

Paige A. Armstrong, Maria Buti, David W. Fitzsimons, Sara Valckx, Greet Hendrickx +2 more

Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS‐CoV ‐2 infection and COVID ‐19 disease severity

The FASEB Journal(2023)10.1096/fj.202300077r

N/A

0DataRank · unranked

5 citations

Candela Manfredi, Frauke Degenhardt, Joseph Conway, Michael Horwath, Courtney McCracken +33 more

A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

Research Square(2023)10.21203/rs.3.rs-3316459/v1

N/A

0DataRank · unranked

0 citations

Francesca Minnai, Filippo Biscarini, Martina Esposito, Tommaso A. Dragani, Luís Bujanda +14 more

A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

Scientific Reports(2024)10.1038/s41598-024-53310-x

N/A

0DataRank · unranked

7 citations

Filippo Biscarini, Martina Esposito, Tommaso A. Dragani, Luís Bujanda, Souad Rahmouni +95 more

Reply to: “Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies”

Journal of Hepatology(2024)10.1016/j.jhep.2024.03.001

N/A

0DataRank · unranked

1 citations

Maria Buti, Pietro Lampertico, Hannah M. Lee, Marc G. Ghany

A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles

The Lancet. Gastroenterology & hepatology(2025)10.1016/s2468-1253(25)00068-8

N/A

0DataRank · unranked

20 citations

Jana Manning, Rania A. Tohme, Maria Buti, Loreta A. Kondili, C Wendy Spearman +36 more

A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles

The Lancet. Gastroenterology & hepatology(2025)10.1016/s2468-1253(25)00069-x

N/A

0DataRank · unranked

12 citations

Jana Manning, Rania A. Tohme, Maria Buti, Loreta A. Kondili, C Wendy Spearman +36 more